BlackRock’s Biofrontera BFRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.74K Hold
4,622
﹤0.01% 5479
2025
Q4
$2.63K Hold
4,622
﹤0.01% 5380
2025
Q3
$4.55K Hold
4,622
﹤0.01% 5274
2025
Q2
$3.29K Hold
4,622
﹤0.01% 5297
2025
Q1
$3.7K Hold
4,622
﹤0.01% 5268
2024
Q4
$5.04K Hold
4,622
﹤0.01% 5221
2024
Q3
$6.15K Hold
4,622
﹤0.01% 5027
2024
Q2
$4.15K Hold
4,622
﹤0.01% 5139
2024
Q1
$7.12K Hold
4,622
﹤0.01% 5114
2023
Q4
$12.8K Hold
4,622
﹤0.01% 5128
2023
Q3
$40.5K Buy
4,622
+1
+0% +$10 ﹤0.01% 5039
2023
Q2
$48.1K Sell
4,621
-1,969
-30% -$20.9K ﹤0.01% 5073
2023
Q1
$80.4K Buy
6,590
+591
+10% +$9.22K ﹤0.01% 5011
2022
Q4
$110K Buy
5,999
+70
+1% +$1.43K ﹤0.01% 5017
2022
Q3
$125K Buy
5,929
+391
+7% +$10.7K ﹤0.01% 5104
2022
Q2
$206K Buy
5,538
+513
+10% +$31.1K ﹤0.01% 5017
2022
Q1
$335K Buy
5,025
+4,519
+893% +$328K ﹤0.01% 4981
2021
Q4
$76K Buy
+506
New +$55.4K ﹤0.01% 5336

Other funds holding BFRI

BlackRock's BFRI Position: Q1 2026 in Review

BlackRock held its Biofrontera (BFRI) position steady in Q1 2026 at 4,622 shares worth $3.74K. The position accounts for ﹤0.01% of the portfolio, ranked #5479.

BlackRock first reported a position in BFRI in Q4 2021 and has held it in 18 quarters since. The position peaked at $335K in Q1 2022. 12 funds tracked by Wall St. Rank hold BFRI as of Q1 2026.

  • BlackRock held 4,622 shares of Biofrontera worth $3.74K as of Q1 2026.
  • BlackRock left its Biofrontera share count unchanged in Q1 2026.
  • Biofrontera made up ﹤0.01% of BlackRock's portfolio in Q1 2026, its #5479 holding.
  • BlackRock first reported a position in Biofrontera in Q4 2021 and has held it in 18 quarters since.
  • BlackRock's Biofrontera position peaked at $335K in Q1 2022.
  • 12 funds tracked by Wall St. Rank held Biofrontera as of Q1 2026.

Based on BlackRock's 13F filing for Q1 2026, filed 13 May 2026.